Thorac Cardiovasc Surg 2008; 56(3): 162-166
DOI: 10.1055/s-2007-989368
Original Thoracic

© Georg Thieme Verlag KG Stuttgart · New York

Thoracoscopic Lobectomy with Systemic Lymph Node Dissection for Lymph Node Positive Non-Small Cell Lung Cancer - Is Thoracoscopic Lymph Node Dissection Feasible?

T. Shiraishi1 , M. Hiratsuka1 , Y. Yoshinaga1 , S. Yamamoto1 , A. Iwasaki1 , T. Shirakusa1
  • 1Department of Surgery II, Fukuoka University School of Medicine, Fukuoka, Japan
Weitere Informationen

Publikationsverlauf

received January 23, 2007

Publikationsdatum:
26. März 2008 (online)

Abstract

Introduction: The impact of thoracoscopic systemic lymph node dissection (LND) on loco-regional control of non-small cell lung cancer (NSCLC) with positive lymph node metastasis was investigated. Patients and Methods: Thoracoscopic lobectomy with systemic LND was performed for clinical stage I NSCLC. 340 patients were admitted for either a thoracoscopic (n = 98) or a standard open (n = 242) lobectomy with systemic LND. Of those 340 cases, 75 cases (20 thoracoscopic and 55 open) were pathologically diagnosed with node-positive disease. A retrospective chart review of these 75 cases was performed. Results: No significant difference in the overall or loco-regional recurrence-free survival was observed between the groups. The results of a multivariate analysis of the overall and the loco-regional recurrence-free survival demonstrated that the significant factors were tumor size for overall recurrence-free survival, and sex and surgical procedure (use of thoracoscopic surgery) for loco-regional recurrence-free survival, respectively. Conclusion: In general, thoracoscopic lobectomy for c-stage I disease may have no survival disadvantage over open procedures. It might, however, increase the risk of local recurrence when used to treat pathologically node-positive disease. Caution should be used when treating those cases with thoracoscopic surgery.

References

  • 1 Shiraishi T, Shirakusa T, Hiratsuka M, Yamamoto S, Iwasaki A. Video-assisted thoracoscopic surgery lobectomy for c-T1N0M0 primary lung cancer; its impact on loco-regional control.  Ann Thorac Surg. 2006;  82 (3) 1021-1026
  • 2 Iwasaki A, Shirakusa T, Shiraishi T, Yamamoto S. Results of video-assisted thoracic surgery for stage I/II non-small cell lung cancer.  Eur J Cardiothorac Surg. 2004;  26 58-64
  • 3 Walker W S, Codispoti M, Soon S Y, Stamenkovic S, Carnochan F, Pugh G. Long-term outcomes following VATS lobectomy for non-small cell bronchogenic carcinoma.  Eur J Cardiothorac Surg. 2003;  23 397-402
  • 4 Gharagozloo F, Tempesta B, Margolis M, Alexander E P. Video-assisted thoracic surgery lobectomy for stage I lung cancer.  Ann Thorac Surg. 2003;  76 1009-1014
  • 5 Shiraishi T, Shirakusa T, Iwasaki A. et al . VATS segmentectomy for small-sized peripheral lung cancer - intermediate results.  Surg Endosc. 2004;  18 1657-1662
  • 6 McKenna R J. VATS lobectomy experience with 1100 cases.  Ann Thorac Surg. 2006;  81 421-426
  • 7 Inada K, Shirakusa T, Yoshinaga Y. et al . The role of video-assisted thoracic surgery for the treatment of lung cancer: lung lobectomy by thoracoscopy versus the standard thoracotomy approach.  Int Surg. 2000;  85 6-12
  • 8 Nomori H, Horio H, Naruke T, Suemasu K. What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery?.  Ann Thorac Surg. 2001;  72 879-884
  • 9 Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure.  Ann Thorac Surg. 2001;  72 362-365
  • 10 Kaseda S, Aoki T, Hangai N, Shimizu K. Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy.  Ann Thorac Surg. 2000;  70 1644-1646
  • 11 Yim A P, Wan S, Lee T W, Arifi A A. VATS lobectomy reduces cytokine responses compared with conventional surgery.  Ann Thorac Surg. 2000;  70 243-247
  • 12 Kawahara K, Iwasaki A, Shiraishi T, Okabayashi K, Shirakusa T. Video-assisted thoracoscopic lobectomy for treating lung cancer.  Surg Laparosc Endosc. 1997;  7 219-222
  • 13 Sugi K, Kaneda Y, Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer.  World J Surg. 2000;  24 27-30
  • 14 Watanabe A, Koyanagi T, Obama T, Ohsawa H, Mawatari T, Takahashi N, Ichimiya Y, Abe T. Assessment of node dissection for clinical stage I primary lung cancer by VATS.  Eur J Cardiothorac Surg. 2005;  27 745-752
  • 15 Sagawa M, Sato M, Sakurada A, Matsumura Y, Endo C, Handa M, Kondo T. A prospective trial of systematic nodal dissection for lung cancer by video-assisted thoracic surgery: can it be perfect?.  Ann Thorac Surg. 2002;  73 900-904

Dr. MD, PhD Takeshi Shiraishi

Department of Surgery II
Fukuoka University School of Medicine

7-45-1 Nanakuma, Jonan-ku, Fukuoka City

814-0180 Fukuoka

Japan

Telefon: + 81 9 28 01 10 11

Fax: + 81 9 28 61 82 71

eMail: tshiraishi-ths@umin.ac.jp